June 12, 2024

The Meals and Drug Administration has issued a brand new warning about counterfeit variations of the burden loss drug Ozempic. 

The company says it seized 1000’s of items of the counterfeit drug. Nonetheless, the FDA believes there are nonetheless items within the U.S. drug provide chain. 

Wholesalers, retail pharmacies, well being care practitioners and sufferers are inspired to test their product’s lot and serial numbers. Merchandise with lot quantity NAR0074 and serial quantity 430834149057 are counterfeit, the FDA.

Novo Nordisk, the producer of Ozempic, and the FDA are reportedly testing the counterfeit product. There’s concern that the medication might not be efficient and will pose security considerations.  

The FDA stated it is already decided that the needles that accompany the counterfeit medication are counterfeit, which means their sterility can’t be confirmed. Use of a non-sterile needle can increase the chance of an infection after the drug is run. 

“FDA is conscious of 5 antagonistic occasions from this lot, none of that are critical and are in step with recognized widespread antagonistic reactions to genuine Ozempic, that are nausea, vomiting, diarrhea, belly ache and constipation,” the company stated in a press release. 

Retail pharmacies are being reminded to solely buy genuine Ozempic by means of licensed distributors. People who find themselves in search of the drug are additionally being reminded that they need to solely acquire Ozempic with a sound prescription by means of a state-licensed pharmacy.

Supply Hyperlink : [randomize]